Search Results - "Fedorova, Liudmila"

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma by Fedorova, Liudmila V., Lepik, Kirill V., Volkov, Nikita P., Kotselyabina, Polina V., Borzenkova, Evgenia S., Popova, Marina O., Beynarovich, Anastasia V., Baykov, Vadim V., Kozlov, Andrey V., Moiseev, Ivan S., Mikhailova, Natalia B., Kulagin, Alexander D.

“…Objectives Therapy of patients with relapsed and refractory classic Hodgkin lymphoma (r/r cHL) after PD-1 inhibitors failure remains an unresolved issue. The…”
Get full text

Mapping the evolution of tourism research: the Spanish case by Martínez-Navarro, Jesús, Campayo-Sánchez, Fernando, Ostrovskaya Fedorova, Liudmila

“…Purpose This study aims to appraise the historical evolution of tourism research focused on Spain. Firstly, an analysis was conducted to assess the production…”
Get full text

Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma by Fedorova, Liudmila V., Lepik, Kirill V., Mikhailova, Natalia B., Kondakova, Elena V., Zalyalov, Yuri R., Baykov, Vadim V., Babenko, Elena V., Kozlov, Andrey V., Moiseev, Ivan S., Afanasyev, Boris V.

“…Immune checkpoint inhibitors (ICI) have demonstrated high therapeutic efficacy in relapsed or refractory classical Hodgkin lymphoma (r/r cHL). Nevertheless,…”
Get full text

P1179: PROGNOSIS OF PATIENTS WITH AGGRESSIVE REFRACTORY B‐NHL TREATED WITH GLOFITAMAB IN REAL CLINICAL PRACTICE by Fedorova, Liudmila, Smykova, Olesia, Kirill, Lepik, Markelov, Vladislav, Popova, Marina, Kondakova, Elena, Moiseev, Ivan, Mikhailova, Natalia, Kulagin, Alexander

Get full text

P062: The efficacy and safety of nivolumab 40 mg therapy versus 3 mg/kg in patients with relapsed and refractory classic Hodgkin lymphoma by Fedorova, Liudmila, Lepik, Kirill, Mikhailova, Natalia, Kondakova, Elena, Komarova, Yaroslava, Kotselyabina, Polina, Borzenkova, Evgenia, Baykov, Vadim, Moiseev, Ivan, Kulagin, Alexander

Get full text

P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment by Fedorova, Liudmila, Lepik, Kirill, Mikhailova, Natalia, Kondakova, Elena, Komarova, Yaroslava, Kotselyabina, Polina, Borzenkova, Evgenia, Baykov, Vadim, Moiseev, Ivan, Kulagin, Alexander

Get full text

A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma by Lepik, Kirill V., Fedorova, Liudmila V., Kondakova, Elena V., Zalyalov, Yuri R., Babenko, Elena V., Lepik, Elena E., Kotselyabina, Polina V., Beynarovich, Anastasia V., Popova, Marina O., Volkov, Nikita P., Stelmakh, Lilia V., Baykov, Vadim V., Moiseev, Ivan S., Mikhailova, Natalia B., Kulagin, Alexander D., Afanasyev, Boris V.

“…Supplemental Digital Content is available in the text The introduction of nivolumab has changed the landscape of relapsed/refractory classical Hodgkin lymphoma…”
Get full text

PB2308: NIVOLUMAB‐BASED THERAPY OF RELAPSED OR REFRACTORY PRIMARY LARGE B‐CELL LYMPHOMA OF IMMUNE‐PRIVILEGED SITES AND DLBCL WITH SECONDARY CNS INVOLVEMENT by Gavrilenko, Andrey, Markelov, Vladislav, Volkov, Nikita, Shmidt, Daniil, Skiba, Yaroslav, Kondakova, Elena, Kirill, Lepik, Fedorova, Liudmila, Popova, Marina, Mikhaylova, Natalya, Kulagin, Alexander

Get full text

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure by Lepik, Kirill V., Mikhailova, Natalia B., Kondakova, Elena V., Zalyalov, Yuri R., Fedorova, Liudmila V., Tsvetkova, Luibov A., Kotselyabina, Polina V., Borzenkova, Evgeniya S., Babenko, Elena V., Popova, Marina O., Darskaya, Elena I., Baykov, Vadim V., Moiseev, Ivan S., Afanasyev, Boris V.

“…Supplemental Digital Content is available in the text This single‐center prospective clinical trial evaluated the combination of nivolumab plus bendamustine…”
Get full text

Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice by Vorobyev, Vladimir I., Gemdzhian, Eduard G., Fedorova, Liudmila V., Mikhailova, Natalia B., Ilyasov, Ridvan K., Kaleikina, Liliia P., Trubyakova, Olga S., Kaplanov, Kamil D., Melnichenko, Elena V., Martynova, Elena V., Yakovleva, Elena P., Li, Olga Yu, Tarasenko, Elena V., Chumakova, Elena P., Bulieva, Natalia B., Nesterova, Ekaterina S., Margolin, Oleg V., Zherebtsova, Vera A., Butaev, Lev S., Ptushkin, Vadim V.

“…Background. Mantle cell lymphoma (MCL) is a rare and clinically aggressive lymphoma subtype. Current approaches have greatly improved patients outcomes, but…”
Get full text

Prognosis of patients with Hodgkin lymphoma and indeterminate response to PD-1 inhibitor therapy: considerations for application of LYRIC criteria in real clinical practice by Fedorova, Liudmila, Lepik, Kirill, Gusak, Artem, Kotselyabina, Polina, Moiseev, Ivan, Baykov, Vadim, Mikhailova, Natalia, Kulagin, Alexander

“…PD-1 inhibitors have shown unconventional response patterns in classic Hodgkin lymphoma (cHL). These include the phenomenon of pseudoprogression, highlighting…”
Get full text

Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations by Gusak, Artem, Fedorova, Liudmila, Lepik, Kirill, Volkov, Nikita, Popova, Marina, Moiseev, Ivan, Mikhailova, Natalia, Baykov, Vadim, Kulagin, Alexander

“…To date, the impact of the tumor microenvironment on the prognosis of patients with classic Hodgkin lymphoma (cHL) during anti-PD-1 therapy has been studied…”
Get full text

La imagen de la mujer en derivados morfológicos y léxico-sintácticos (según fuentes lexicográficas en ruso y español) by Iakovleva, Svetlana, Fedorova, Liudmila

“…La dinámica de la imagen de la mujer se analiza a ejemplo de los derivados morfológicos y léxico-sintácticos y sus significados léxicos, registrados en los…”
Get full text

The Outcomes of Nivolumab Fixed Dose 40 Mg Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma by Fedorova, Liudmila, Lepik, Kirill, Kotselyabina, Polina, Kondakova, Elena, Zalyalov, Yuri, Borzenkova, Evgeniya, Baykov, Vadim, Epifanovskaya, Olga S., Babenko, Elena V., Moiseev, Ivan S., Kulagin, Aleksander, Mikhailova, Natalia, Afanasyev, Boris

“…▪ Background Currently, the recommended dose of nivolumab for patients with relapsed or refractory classical Hodgkin lymphoma (r/r сHL) is 3 mg/kg…”
Get full text

Russo e italiano nei contatti linguistici: immagini riflesse by Liudmila L'vovna Fedorova, Michela Bolognani

“…The paper aims to enlighten the image of Italy through Russian and the image of Russia through Italian in the mutual lexical input of languages. Language…”
Get full text

Heating and electrochemical processing of liquids in induction systems with coaxial cylinders by Khatsevskiy, Konstantin V., Fedorova, Liudmila D., Gonenko, Tatjana V.

“…A new type of induction systems for heating and electrical semiconductor processing liquids with ionic conductivity in electromagnetic fields is considered in…”
Get full text